Fougera Pharms Drug Patent Portfolio
Fougera Pharms owns 2 orange book drugs protected by 7 US patents Given below is the list of Fougera Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7300669 | Fluticasone lotion having improved vasoconstrictor activity | 20 Oct, 2019 | Expired |
| US5792753 | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs | 11 Aug, 2015 | Expired |
| US5914322 | Treatment of disease and conditions | 11 Aug, 2015 | Expired |
| US5985850 | Compositions comprising hyaluronic acid and drugs | 11 Aug, 2015 | Expired |
| US5639738 | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs | 17 Jun, 2014 | Expired |
| US5852002 | Treatment of conditions and disease | 17 Jun, 2014 | Expired |
| US5929048 | Treatment of conditions and disease | 17 Jun, 2014 | Expired |
Latest Legal Activities on Fougera Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Fougera Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 May, 2019 | US7300669 |
|
Email Notification
Critical
| 07 Oct, 2011 | US7300669 |
| Grant Request for Retroactive License | 21 Sep, 2011 | US7300669 |
|
Email Notification
Critical
| 31 May, 2011 | US7300669 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 31 May, 2011 | US7300669 |
|
Correspondence Address Change
Critical
| 26 May, 2011 | US7300669 |
| Request for Retroactive License | 23 Dec, 2010 | US7300669 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Nov, 2007 | US7300669 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Nov, 2007 | US7300669 |
|
Issue Notification Mailed
Critical
| 07 Nov, 2007 | US7300669 |
| Dispatch to FDC | 29 Oct, 2007 | US7300669 |
|
Application Is Considered Ready for Issue
Critical
| 09 Oct, 2007 | US7300669 |
|
Issue Fee Payment Received
Critical
| 04 Oct, 2007 | US7300669 |
| Reverse Issue Fee | 04 Oct, 2007 | US7300669 |
|
Issue Fee Payment Verified
Critical
| 04 Oct, 2007 | US7300669 |
Fougera Pharms's Family Patents
Fougera Pharms Drug List
Given below is the complete list of Fougera Pharms's drugs and the patents protecting them.
1. Cutivate
Cutivate is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7300669 | Fluticasone lotion having improved vasoconstrictor activity |
20 Oct, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cutivate's drug page
2. Solaraze
Solaraze is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5792753 | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
11 Aug, 2015
(9 years ago)
| Expired |
| US5914322 | Treatment of disease and conditions |
11 Aug, 2015
(9 years ago)
| Expired |
| US5985850 | Compositions comprising hyaluronic acid and drugs |
11 Aug, 2015
(9 years ago)
| Expired |
| US5639738 | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
17 Jun, 2014
(10 years ago)
| Expired |
| US5852002 | Treatment of conditions and disease |
17 Jun, 2014
(10 years ago)
| Expired |
| US5929048 | Treatment of conditions and disease |
17 Jun, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Solaraze's drug page